A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries
- Maria Victoria Humbert
- , Precious Chinonyerem Opurum
- , Nathan J. Brendish
- , Stephen Poole
- , Peijun He
- , Ioannis Katis
- , Jerry Quaye
- , Yaw Bediako
- , Patrick Jacques Duriez
- , Robert W. Eason
- , Collin Sones
- , Osbourne Quaye
- , Gordon A. Awandare
- , Myron Christodoulides
- , Tristan W. Clark
- , Peter K. Quashie
- , Christopher J. McCormick
- University of Southampton
- University of Ghana
- University Hospital Southampton NHS Foundation Trust
- University of Southampton
Research output: Contribution to journal › Article › peer-review
13
Citations
(Scopus)